Market growth can largely
be attributed to the rising demand for animal-derived food products, increasing
incidence of zoonotic diseases, and the implementation of regulations to
prevent the spread of animal diseases. Rising animal healthcare spending and
the growing demand for pet insurance are further expected to drive the growth
of this market. The untapped emerging markets such as China, India, and Brazil
and growth in the overall companion animal population are also expected to
offer significant growth opportunities to market players in the coming years
The global animal
antimicrobials and antibiotics market is projected to reach USD 5.6 billion by
2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353
However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.
The prominent players in
the animal antimicrobials and antibiotics market are Boehringer Ingelheim
(Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc
(US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France),
Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku
(Japan), Tianjin Ringpu (China), HIPRA (Spain), Zydus Animal Health (US), China
Animal Husbandry (China), and Inovet (Belgium).
ZOETIS, INC.
Zoetis accounted for the
largest share of the animal antimicrobials and antibiotics market in 2020. The
company provides highly diversified products for a wide range of animal
species. The company’s broad geographic diversity has enabled it to deliver its
animal healthcare products to more than 110 countries worldwide. To maintain
its position in the animal antimicrobials and antibiotics market, the company
focuses on providing innovative products, building a strong geographical
network, and enhancing its R&D capabilities to deliver measurable and
beneficial results for animals.
MERCK & CO.
Merck accounted for
second largest of the market in 2020. The company’s strong focus on
a broad range of animals, investments in collaborations & partnerships, and
comprehensive quality systems and processes are driving its growth in the
market. It focuses on acquisitions, expansions, and collaborations, as well as
product launches. In March 2017, Merck Animal Health (known as MSD Animal
Health in the US and Canada) acquired Vallée S.A., a leading privately-held
producer of animal health products in Brazil. This helped Merck offer a comprehensive
portfolio of products for livestock animals and expand its reach in Latin
America.
ELANCO ANIMAL HEALTH
Elanco Animal Health is one of the largest players in the animal antimicrobials and antibiotics market in 2020. To remain competitive and grow, the company focuses on expanding and strengthening its partnerships with existing customers, enhancing operations and quality, enhancing capabilities and expertise, and developing innovative products. The company pursues growth through a number of organic and inorganic growth strategies, such as product launches, expansions, acquisitions, agreements, partnerships, collaborations, and divestitures, to broaden its product portfolio and grow its existing business segments. In August 2019, Elanco acquired Bayer’s Animal Health business. This acquisition doubled Elanco’s companion animal business and advanced the company’s portfolio mix by creating a balance between its food animal and companion animal segments.
BOEHRINGER INGELHEIM
Boehringer Ingelheim was
one of the leading player in the animal antimicrobials and antibiotics market
in 2020. The company’s strong focus on R&D and investments in
collaborations, partnerships, and acquisitions have ensured its position in the
market. It focuses on expansions to strengthen its geographic footprint,
presence, and growth. In August 2019, Boehringer opened a Health Management
Center in China. The center integrates animal disease and health diagnostics as
well as provides monitoring tools to maintain and enhance animal health.